市場調查報告書
商品編碼
1403422
到 2030 年超音波設備的市場預測:按產品、應用、最終用戶和地區進行的全球分析Ultrasound Equipment Market Forecasts to 2030 - Global Analysis By Product (Compact, Table Top and Other Products), Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球超音波設備市場規模將達到 95 億美元,預計到 2030 年將達到 177 億美元,預測期內複合年成長率為 9.3%。
使用高頻聲波在體內產生影像的設備稱為超音波設備。器官、組織和身體結構(包括肌肉、肌腱、關節以及心臟、肝臟和腎臟等內臟器官)的可視化是典型的醫學診斷技術。當超音波診斷設備發出的聲波在結構內反射時,它們會產生影像,醫療專業人員可以使用這些影像來診斷和追蹤疾病的進展。
根據英國NHS 2021年12月公佈的資料,2020年8月至2021年8月期間,英國約有944萬名NHS患者接受了超音波診斷。
超音波影像成像系統的技術進步
技術創新是驅動市場的關鍵因素。超音波技術的持續創新和進步正在改變整個產業。彈性成像、增強移動性、3D/4D 成像和 AI 整合等尖端功能正在改變診斷能力並顯著改善患者照護。這些技術進步提高了診斷測試的速度和準確性,並改善了治療計劃。
有限報銷政策
醫療報銷不足可能會阻礙超音波技術的進步。報銷減少可能會限制分配給醫療保健專業人員超音波設備培訓的資金。醫療費用的下降可能會阻礙醫療機構投資最新的超音波設備。為了省錢,他們可能會選擇使用過時或不成熟的技術,這將影響診斷的準確性和精確度。這是阻礙市場擴張的方面。
越來越重視即時診斷 (POC)
由於照護端超音波診斷的使用不斷增加,該市場正在顯著成長。它解釋了醫療保健專業人員如何在患者床邊使用超音波來快速診斷和治療患者。這些設備體積小、重量輕,通常由電池供電,可以在困難的情況下進行現場護理。透過普及貧困地區,我們可以改善整體醫療保健可近性並解決未滿足的醫療保健需求。超音波檢測服務現在變得越來越廣泛。
維護和升級成本高
超音波設備的初始購買成本較高,這對於小型醫院或人口稀少地區的醫院來說可能是一個主要障礙。由於需要設備升級和持續維護以跟上技術進步,醫療保健組織可能面臨財務挑戰。此外,在資源有限且預算緊張的醫療保健環境中,超音波設備的高成本可能會阻礙其廣泛普及。
COVID-19 的爆發對超音波市場產生了整體負面影響。疫情擾亂了全球醫療設備供應鏈。市場上一些最大的公司正面臨供應鏈中斷,特別是來自新興國家分銷商的供應鏈中斷,這些公司受到的影響尤其嚴重。另一方面,由於原料和零件無法在地採購,一些製造商的製造能力受到影響。
放射學產業預計將成為預測期內最大的產業
由於放射學領域人工智慧應用的增加,預計放射學領域在預測期內將出現最大的成長。 Caption AI 技術加快並簡化了超音波檢查,讓更多醫療保健專業人員能夠進行基本的心臟超音波圖。該設備可以識別任何地方(包括醫院、家庭和其他院外環境)高風險族群的疾病症狀,包括心臟衰竭。這減少了住院時間並改善了患者的治療效果。
預計醫院領域在預測期內的複合年成長率最高。
在預測期內,由於超音波設備在醫院環境中的廣泛使用,醫院部門預計將出現最高的複合年成長率。隨著攜帶式系統的引入,預計 OPD 和住院部對超音波設備的需求將會增加。此外,尖端影像處理系統的使用增加以及醫院和行業併購的增加活性化推動未來幾年對新設備的需求。
預計北美在預測期內將佔據最大的市場佔有率。該地區眾多競爭的存在和癌症患者數量的增加是促進該地區市場成長的主要因素。醫療保健支出的增加、對各種診斷方法的更好理解以及有利的報銷政策預計將推動該地區的市場成長。
由於對更好的診斷影像設備的需求不斷增加,預計亞太地區在預測期內將保持最高的複合年成長率。此外,主要企業正在採取各種策略來加強其在該地區的影響力。較低的研究成本、寬鬆的監管指南以及各國政府增加的研發資金等因素使該地區成為具有吸引力的研發地區。
According to Stratistics MRC, the Global Ultrasound Equipment Market is accounted for $9.5 billion in 2023 and is expected to reach $17.7 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Devices that create pictures of the inside of the body using high-frequency sound waves are referred to as ultrasound equipment. Visualizing organs, tissues, and bodily structures, including muscles, tendons, joints, and internal organs like the heart, liver, and kidneys, is a typical medical diagnostic technique. When sound waves are emitted by ultrasound devices and bounce off inside structures, pictures are produced that medical practitioners can use to diagnose ailments or track the course of diseases.
According to a data published by NHS England in December 2021, around 9.44 million NHS patients in the U.K., underwent diagnostic ultrasonography from August 2020 to August 2021.
Innovations in technology are key factors driving the market. Due to ongoing innovation and advancements in ultrasonography technology, the industry is undergoing a major change. Cutting-edge features including elastography, improved mobility, 3D/4D imaging, and AI integration are transforming diagnostic capabilities and greatly enhancing patient care. These technological advancements improve treatment planning in addition to improving diagnostic tests speed and accuracy.
Insufficient reimbursement might hinder the advancement of ultrasound technologies. Decreased reimbursement rates may restrict the amount of funds allotted for ultrasound equipment training for medical personnel. Lower reimbursement might deter medical institutions from investing in the newest ultrasound equipment. To save money, they can choose to use outdated or less sophisticated technology, which would affect the precision and caliber of diagnosis. This is the aspect preventing the market from expanding.
The market is seeing significant growth due to the growing use of point-of-care ultrasonography. It describes how medical professionals utilize ultrasound at the patient's bedside to quickly diagnose and treat patients. These devices allow point-of-care usage even in difficult circumstances since they are small, light, and frequently battery-operated. By reaching underprivileged communities, this increases the accessibility of healthcare overall and addresses unmet healthcare needs. Ultrasound services are now more widely available.
Ultrasound equipment can be expensive to buy initially, which can be a major barrier for smaller hospitals or those in underdeveloped areas. Healthcare institutions may face financial difficulties due to the requirement for equipment upgrades to stay up with technological breakthroughs and ongoing upkeep. Furthermore, in healthcare settings with limited resources and tight budgets, the high cost of ultrasound instruments may prevent them from being widely available.
The outbreak of COVID-19 has had an overall negative effect on the ultrasound market. The pandemic has generated disruptions in the supply chain of medical devices globally. Some of the major players operating in the market have faced supply chain disruptions especially from distributors in severely impacted emerging countries. On the other hand, the manufacturing capacity of a few players has been affected due to the unavailability of locally sourced raw materials or parts.
The radiology segment is expected to be the largest during the forecast period owing to increasing application of artificial intelligence in radiology. Caption AI technologies can expedite and simplify ultrasonic examinations, enabling more medical personnel to do basic echocardiography exams. This gadget can recognize symptoms of illnesses, including heart failure, in individuals who are at risk anywhere-in hospitals, homes, and other out-of-hospital settings. This reduces hospital stays and improves patient outcomes.
The hospitals segment is expected to have the highest CAGR during the forecast period owing to the extensive use of ultrasound devices in hospital settings. The need for ultrasound equipment in OPD and in-patient departments is anticipated to increase with the introduction of portable systems. In addition, a growth in the use of cutting-edge imaging systems and a rise in hospital and industry merger and acquisition activity are probably going to drive up demand for new installations in the upcoming years.
North America is projected to hold the largest market share during the forecast period. The presence of a significant number of competitors in the region and an increasing number of cancer cases are key factors contributing to regional market growth. Increasing expenditure on healthcare, a greater understanding of various methods of diagnosis, and favorable policies for reimbursement are projected to drive regional market growth.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the increased demand for better imaging devices. Furthermore, key players are adopting different strategies to strengthen their presence in this region. Factors, such as low research costs, less stringent regulatory guidelines, increased government funding for the R&D sector's development in the respective countries, are making the region attractive for research studies.
Some of the key players in Ultrasound Equipment market include Philips Healthcare, Canon Medical Systems Corp, Hitachi Healthcare Manufacturing Ltd, Samsung Medison Co Ltd, GE Healthcare, Siemens Healthineers AG, Fujifilm Holdings Corp, Esaote SpA, Mindray, Analogic Corporation, Sonosite, Toshiba Medical Systems and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
In March 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched new handheld ultrasound device TE Air, that provides enhanced point-of-care ultrasound imaging with an array of practical benefits for radiologists.
In February 2022, Koninklijke Philips N.V., launched Lumify, its handheld point-of-care ultrasound solution for expanding its portfolio to offer advanced hemodynamic assessment and measurement capabilities.